Efficacy of SXN in the Treatment of Iron Deficiency Anemia: A Phase IV Clinical Trial

Table 4

Safety index results before and after medication.

Blood tests	Number of tested cases	Normal pre-treatment		Abnormal pre-treatment
		Normal post-treatment	Abnormal post-treatment	Normal post-treatment	Abnormal post-treatment
ALT	1122	990	0	58	74
BUN	1139	974	0	63	102
Cr	1143	997	0	74	72